Kaposi's sarcoma in women: A clinicopathologic study

Journal of Cutaneous Medicine and Surgery

Volumn 3, Issue 3, 1999, Pages 132-139

  Smith, Kathleen J ^a   Nelson, Ann ^a   Angritt, Peter ^b   Morz, Al ^b   Skelton, Henry G ^c  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^c LABORATORY CORPORATION OF AMERICA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOSARCOMA; ARTICLE; CANCER STAGING; CAUSE OF DEATH; CELL PROLIFERATION; DERMADROME; ENDEMIC DISEASE; FEMALE; HISTOLOGY; HUMAN; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MITOSIS RATE; PLAQUE FORMING CELL; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; SKIN DEFECT; TUMOR CELL;

EID: 0032903427     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.1177/120347549900300305     Document Type: Article

References (54)

1. Sankey EA, Moore L, Dhillon AP. QBEnd/10: a new immunostain for the routine diagnosis of Kaposi's sarcoma. J Pathol 1990; 161:267-271.
2. Schlingemann RO, Rietveld FJR, DeWaal MW, et al. Leukocyte antigen CD34 is expresssed by a subset of cultured endothelial cells and endothelial abluminal microprocesses in the tumour stroma. Lab Invest 1990; 62:690-696.
3. Peterman TA, Jaffe HW, Beral B. Epidemiologic clues to the etiology of Kaposi's sarcoma. AIDS 1993; 7:605-611.
4. Desmond-Hellmann SD, Katongole-Mbidde E. Kaposi's sarcoma: recent development. AIDS 1991; 5:135S-142S.
5. Tappero JW, Conant MA, Wolfe SF, et al. Kaposi's sarcoma: epidemiology, pathogenesis, histology, clinical spectrum, staging criteria, and therapy. J Am Acad Dermatol 1993; 28:371-376.
6. Plettenberg A, Meigel W Endemic Kaposi's sarcoma - etiopathogenesis, epidemiology, clinical presentation and therapy. Allergologie 1994; 7:295-302.
7. Lospalluti M, Mastrolonardo M, Locaansole F, et al. Classical Kaposi's sarcoma: a survey of 163 cases observed in Bari, south Italy. Dermatology 1995; 191:104-108.
8. Freidman-Klein AE, Saltzman BR. Clincal manifestations of classical, endemic African, and epidemic AIDS-associated Kaposi's sarcoma. J Am Acad Dermatol 1990; 22:1237-1250.
9. Smith KJ, Skelton HG 3d, James WD, et al. Angiosarcoma arising in Kaposi's sarcoma (pleomorphic Kaposi's sarcoma) in a patient with human immunodeficiency virus disease. J Am Acad Dermatol 1991; 24:790-792.
10. Huang YQ, Li JJ, Kaplan MH, et al. Human herpes-like nucleic acid in various forms of Kaposi's sarcoma. Lancet 1995; 345: 759-761.
11. Lee H, Veazey R, Williams K, et al. Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus. Nature Med 1998; 4:435-440.
12. Klepp O, Dahl O, Stenwig JT. Association of Kaposi's sarcoma and prior immunosuppressive therapy: a 5-year material of Kaposi's sarcoma in Norway. Cancer 1978; 42:2626-2630.
13. Harwood AR, Osoba D, Hofstader SL, et al. Kaposi's sarcoma in recipients of renal transplants. Am J Med 1979; 67:759-765.
14. Penn I. Kaposi's sarcoma in organ transplant recipients. Transplantation 1979; 27:8-11.
15. Hardy MA, Goldfarb P, Levine S, et al. De novo Kaposi's sarcoma in renal transplantation: case report and brief review. Cancer 1976; 38:144-148.
16. Lesnoni La Parola I, Masini C, Nianni G, et al. Kaposi's sarcoma in renal-transplant receipients: experience at the Catholic University in Rome, 1988-1996. Dermatology 1997; 150:229-233.
17. Gill PS, Loureiro C, Bierstein-Singer M, et al. Clinical effect of glucocorticoids on Kaposi's sarcoma related to the acquired immunodeficiency syndrome (AISA). Ann Intern Med 1989; 110:937-940.
18. Selk RM, Starcher ET, Cubran JW. Opportunistic diseases reported in AIDS patients: frequencies, associations, and trends. AIDS 1987; 1:175-182.
19. Arbiawe JL. Angiogenesis and the skin: a primer. J Am Acad Dermatol 1996; 34:486-497.
20. Cheng EH, Nicholas J, Bellows DS, et al. A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus B, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc Natl Acad Sci USA 1997; 94:690-694.
21. Morris CB, Gendelman R, Marrogi AJ, et al. Immunohistochemical detection of Bcl-2 in AIDS-associated and classical Kaposi's sarcoma. Am J Pathol 1996; 148:1055-1063.
22. Foreman KE, Wrane-Smith T, Boise LH, et al. Kaposi's sarcoma tumour cells preferentially express Bcl-xL. Am J Pathol 1996; 149:795-803.
23. Hammer SM. Advances in antiretroviral therapy and viral load monitoring. AIDS 1996; 10:1S-11S.
24. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpes-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266:1865-1869.
25. Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma patients with and without HIV infection. N Engl J Med 1995; 332:1181-1185.
26. Galdano G, Cechova K, Chang Y, et al. Establishement of AIDS-related lymphoma cell lines from lymphomatous effusions. Leukemia 1996; 10:1237-1240.
27. Gessain A, Sudaka A, Briere J, et al. Kaposi's sarcoma-associated herpes-like virus (human herpesvirus type 8) DNA sequences in multicentric Castleman's disease; is there any relevant association in non-human immunodeficiency virus-infected patients? Blood 1996; 87:414-416.
28. Pollack MS, Safai B, Myskowski PL, et al. Frequencies of HLA and Gm immunogenetic markers in Kaposi's sarcoma. Tissue Antigens 1983; 21:1-8.
29. Papasteriades C, Kaloterakis A, Filiotou A, et al. Histocompatibility antigen HLA-A.-B.-DR in Greek patients with Kaposi's sarcoma. Tissue Antigens 1984; 24:313-315.
30. Conta L, Cerimele D, Pintus A, et al. HLA and Kaposi's sarcoma in Sardinia. Tissue Antigens 1984; 23:240-245.
31. Mebye M, Kestens L, Biggar RI, et al. HLA studies of endemic African Kaposi's sarcoma patients and matched controls: no association with HLA-DR5. Int. J Cancer 1987; 39:182-184.
32. Branbilia L, Boneschi V, Meloti E, Maring C. Significance of genetic factors in familial Kaposi's sarcoma: report of two cases. Ann Int Dermatol Clin Sper 1985; 39:193-201.
33. Finzi AF. Mediterranean Kaposi's sarcoma. Int Gen Rev Dermatol 1986; 23:11-27.
34. Marinig C, Fiorini G, Boneschi V, et al. Immunologic and immunogenetic features of primary Kaposi's sarcoma. Cancer 1985; 55:1899-1901.
35. D'Amato RJ, Lin CM, Flynn E, et al. 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the cholchicine site. Proc Natl Acad Sci USA 1994; 91:3964-3968.
36. Lunardi-Iskandar Y, Bryant JL, Zeman RA, et al. Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone. Nature 1995; 375:64-68.
37. Turelli U, Tavio M, Giacca M, De Paoli P. Human chorionic gondotrophin in the treatment of HIV-related Kaposi's sarcoma. AIDS 1997; 11:387-388.
38. Folkman J, Ingber DE. Angiostatic steroids: methods of discovery and mechanisms of action Ann Surg 1987; 206:373-384.
39. Lunardi-Iskandar Y, Bryant JL, Blattner WA, et al. Effects of urinary factor from women in early pregnancy on HIV-1, SIV and associated disease. Nature Med 1998; 4:428-434.
40. Templeton AC. Pathology in Kaposís sarcoma: pathophysiology and clinical management. In: Ziegler JL, Dorfman RE, eds. New York: Marcel Dekker, 1988:23-70.
41. Miles SA, Rezai AR, Logan D, et al. AIDS Kaposi's sarcoma-derived cells produce and respond to interleukin-6. International Conference on AIDS. San Francisco, June 1990 {Abstr SA66}.
42. Delli Bovi P, Curatola AM, Kern FG, et al. An oncogene isolated by transfection of Kaposi's sarcoma DNA encodes a growth factor that is a member of the FGF family. Cell 1987; 50:729-737.
43. Nakamura S, Salhuddin SZ, Biberfeld P, et al. Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells. Science 1988; 242:426-430.
44. Salhuddin SZ, Nakamura S, Biberfeld P, et al. Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro. Science 1988; 242:430-433.
45. Vogel J, Hinrichs SH, Reynolds RK, et al. The HIV tat gene induces denial lesions resembling Kaposi's sarcoma in transgenic mice. Nature 1988; 335:606-610.
46. Ensoli B, Barillari G, Salhuddin SZ, et al. HIV-1 Tat protein released during acute infection stimulates growth of spindle cells derived from AIDS Kaposi's sarcoma. International Conference on AIDS. San Francisco, June 1990 {Abstr ThA331}.
47. Miles SA, Marinez-Maza E, Rezai A, et al. Oncostatin M as a potent mitogen for AIDS Kaposi sarcoma-derived cells. Science 1992; 255:1432-1434.
48. Gearing DP, Corneau MR, Friend DJ, et al. The IL-6 signal transducer, gp130, an oncostatin M receptor and affinity converter for the LIF receptor. Science 1992; 255:1434-1437.
49. Karp JE, Pluda JM, Yarchoan R. AIDS-related Kaposi's sarcoma. A template for the translation of molecular pathogenesis into targeted therapeutic approaches. Hematol Oncol Clin North Am 1996; 10:1031S-1049S.
50. Kieff E, Liebowitz D. Epstein-Barr virus. In: Fields BN, Knipe DM, eds. Fundamental virology, 2nd Ed. New York: Raven Press, 1991:897-928.
51. Scadden DT. Mother knows best. Nature Med 1998; 4:390-391.
52. Digiovanna JJ, Safai B. Kaposí's sarcoma: retrospective study of 90 cases with particular emphasis on the familial occurrence, ethnic background and prevalence of other diseases. Am J Med 1981; 71:779-783.
53. Dorffel J. Histogenesis of multiple idopathic hemorrhagic sarcoma of Kaposi. Arch Dermatol Syphilol 1932; 26:608-634.
54. Schirren CG, Roth WK, Hein R, et al. Invasive migration of epidemic Kaposi's sarcoma cells in vitro. Br J Dermatol 1990; 123:313-318.